Global Orally Disintegrating Tablet Market Research Report 2022(Status and Outlook)

June 2022 | 112 pages | ID: G8B4A5978BEFEN
Bosson Research

Abstracts

Report Overview

An orally disintegrating tablet or orally dissolving tablet (ODT) is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.

Global Orally Disintegrating Tablet main manufactuers include Teva, Merck, Mylan, Pfizer, Johnson and Johnson, GSK, Otsuka, Eli Lilly and Company, AstraZeneca, Bristol-Myers Squibb and Conquer, totally accounting for about 17% of the market. North America is the largest market of glass packaging, holding a share more than 4%. As for the types of products, it can be divided into anti-psychotics drug, anti-epileptics drug and others. As for the applications of products, it is widely used in CNS diseases, gastrointestinal diseases, CVS diseases and others. The most common application is in CNS diseases packaging, with a share about 55%.

The Global Orally Disintegrating Tablet Market Size was estimated at USD 12403.63 million in 2021 and is projected to reach USD 27108.39 million by 2028, exhibiting a CAGR of 11.82% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Orally Disintegrating Tablet market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Orally Disintegrating Tablet Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Orally Disintegrating Tablet market in any manner.

Global Orally Disintegrating Tablet Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

• Teva
• Merck
• Mylan
• Pfizer
• Johnson and Johnson
• GSK
• Otsuka
• Eli Lilly and Company
• AstraZeneca
• Bristol-Myers Squibb
• Conquer

Market Segmentation (by Type)

• Anti-Psychotics Drug
• Anti-Epileptics Drug
• Others

Market Segmentation (by Application)

• CNS Diseases
• Gastrointestinal Diseases
• CVS Diseases
• Others

Geographic Segmentation

• North America (USA, Canada, Mexico)
• Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
• Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
• South America (Brazil, Argentina, Columbia, Rest of South America)
• The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

• Industry drivers, restraints, and opportunities covered in the study
• Neutral perspective on the market performance
• Recent industry trends and developments
• Competitive landscape & strategies of key players
• Potential & niche segments and regions exhibiting promising growth covered
• Historical, current, and projected market size, in terms of value
• In-depth analysis of the Orally Disintegrating Tablet Market
• Overview of the regional outlook of the Orally Disintegrating Tablet Market:

Key Reasons to Buy this Report:

• Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
• This enables you to anticipate market changes to remain ahead of your competitors
• You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
• The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Orally Disintegrating Tablet Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.

Contents

1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE

1.1 Market Definition and Statistical Scope of Orally Disintegrating Tablet
1.2 Key Market Segments
  1.2.1 Orally Disintegrating Tablet Segment by Type
  1.2.2 Orally Disintegrating Tablet Segment by Application
1.3 Methodology & Sources of Information
  1.3.1 Research Methodology
  1.3.2 Research Process
  1.3.3 Market Breakdown and Data Triangulation
  1.3.4 Base Year
  1.3.5 Report Assumptions & Caveats

2 ORALLY DISINTEGRATING TABLET MARKET OVERVIEW

2.1 Global Market Overview
  2.1.1 Global Orally Disintegrating Tablet Market Size (M USD) Estimates and Forecasts (2017-2028)
  2.1.2 Global Orally Disintegrating Tablet Sales Estimates and Forecasts (2017-2028)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region

3 ORALLY DISINTEGRATING TABLET MARKET COMPETITIVE LANDSCAPE

3.1 Global Orally Disintegrating Tablet Sales by Manufacturers (2017-2022)
3.2 Global Orally Disintegrating Tablet Revenue Market Share by Manufacturers (2017-2022)
3.3 Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Orally Disintegrating Tablet Average Price by Manufacturers (2017-2022)
3.5 Manufacturers Orally Disintegrating Tablet Sales Sites, Area Served, Product Type
3.6 Orally Disintegrating Tablet Market Competitive Situation and Trends
  3.6.1 Orally Disintegrating Tablet Market Concentration Rate
  3.6.2 Global 5 and 10 Largest Orally Disintegrating Tablet Players Market Share by Revenue
  3.6.3 Mergers & Acquisitions, Expansion

4 ORALLY DISINTEGRATING TABLET INDUSTRY CHAIN ANALYSIS

4.1 Orally Disintegrating Tablet Industry Chain Analysis
4.2 Market Overview and Market Concentration Analysis of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis

5 THE DEVELOPMENT AND DYNAMICS OF ORALLY DISINTEGRATING TABLET MARKET

5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
  5.5.1 New Product Developments
  5.5.2 Mergers & Acquisitions
  5.5.3 Expansions
  5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies

6 ORALLY DISINTEGRATING TABLET MARKET SEGMENTATION BY TYPE

6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Orally Disintegrating Tablet Sales Market Share by Type (2017-2022)
6.3 Global Orally Disintegrating Tablet Market Size Market Share by Type (2017-2022)
6.4 Global Orally Disintegrating Tablet Price by Type (2017-2022)

7 ORALLY DISINTEGRATING TABLET MARKET SEGMENTATION BY APPLICATION

7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Orally Disintegrating Tablet Market Sales by Application (2017-2022)
7.3 Global Orally Disintegrating Tablet Market Size (M USD) by Application (2017-2022)
7.4 Global Orally Disintegrating Tablet Sales Growth Rate by Application (2017-2022)

8 ORALLY DISINTEGRATING TABLET MARKET SEGMENTATION BY REGION

8.1 Global Orally Disintegrating Tablet Sales by Region
  8.1.1 Global Orally Disintegrating Tablet Sales by Region
  8.1.2 Global Orally Disintegrating Tablet Sales Market Share by Region
8.2 North America
  8.2.1 North America Orally Disintegrating Tablet Sales by Country
  8.2.2 U.S.
  8.2.3 Canada
  8.2.4 Mexico
8.3 Europe
  8.3.1 Europe Orally Disintegrating Tablet Sales by Country
  8.3.2 Germany
  8.3.3 France
  8.3.4 U.K.
  8.3.5 Italy
  8.3.6 Russia
8.4 Asia Pacific
  8.4.1 Asia Pacific Orally Disintegrating Tablet Sales by Region
  8.4.2 China
  8.4.3 Japan
  8.4.4 South Korea
  8.4.5 India
  8.4.6 Southeast Asia
8.5 South America
  8.5.1 South America Orally Disintegrating Tablet Sales by Country
  8.5.2 Brazil
  8.5.3 Argentina
  8.5.4 Columbia
8.6 Middle East and Africa
  8.6.1 Middle East and Africa Orally Disintegrating Tablet Sales by Region
  8.6.2 Saudi Arabia
  8.6.3 UAE
  8.6.4 Egypt
  8.6.5 Nigeria
  8.6.6 South Africa

9 KEY COMPANIES PROFILED

9.1 Teva
  9.1.1 Teva Orally Disintegrating Tablet Basic Information
  9.1.2 Teva Orally Disintegrating Tablet Product Overview
  9.1.3 Teva Orally Disintegrating Tablet Product Market Performance
  9.1.4 Teva Business Overview
  9.1.5 Teva Orally Disintegrating Tablet SWOT Analysis
  9.1.6 Teva Recent Developments
9.2 Merck
  9.2.1 Merck Orally Disintegrating Tablet Basic Information
  9.2.2 Merck Orally Disintegrating Tablet Product Overview
  9.2.3 Merck Orally Disintegrating Tablet Product Market Performance
  9.2.4 Merck Business Overview
  9.2.5 Merck Orally Disintegrating Tablet SWOT Analysis
  9.2.6 Merck Recent Developments
9.3 Mylan
  9.3.1 Mylan Orally Disintegrating Tablet Basic Information
  9.3.2 Mylan Orally Disintegrating Tablet Product Overview
  9.3.3 Mylan Orally Disintegrating Tablet Product Market Performance
  9.3.4 Mylan Business Overview
  9.3.5 Mylan Orally Disintegrating Tablet SWOT Analysis
  9.3.6 Mylan Recent Developments
9.4 Pfizer
  9.4.1 Pfizer Orally Disintegrating Tablet Basic Information
  9.4.2 Pfizer Orally Disintegrating Tablet Product Overview
  9.4.3 Pfizer Orally Disintegrating Tablet Product Market Performance
  9.4.4 Pfizer Business Overview
  9.4.5 Pfizer Orally Disintegrating Tablet SWOT Analysis
  9.4.6 Pfizer Recent Developments
9.5 Johnson and Johnson
  9.5.1 Johnson and Johnson Orally Disintegrating Tablet Basic Information
  9.5.2 Johnson and Johnson Orally Disintegrating Tablet Product Overview
  9.5.3 Johnson and Johnson Orally Disintegrating Tablet Product Market Performance
  9.5.4 Johnson and Johnson Business Overview
  9.5.5 Johnson and Johnson Orally Disintegrating Tablet SWOT Analysis
  9.5.6 Johnson and Johnson Recent Developments
9.6 GSK
  9.6.1 GSK Orally Disintegrating Tablet Basic Information
  9.6.2 GSK Orally Disintegrating Tablet Product Overview
  9.6.3 GSK Orally Disintegrating Tablet Product Market Performance
  9.6.4 GSK Business Overview
  9.6.5 GSK Recent Developments
9.7 Otsuka
  9.7.1 Otsuka Orally Disintegrating Tablet Basic Information
  9.7.2 Otsuka Orally Disintegrating Tablet Product Overview
  9.7.3 Otsuka Orally Disintegrating Tablet Product Market Performance
  9.7.4 Otsuka Business Overview
  9.7.5 Otsuka Recent Developments
9.8 Eli Lilly and Company
  9.8.1 Eli Lilly and Company Orally Disintegrating Tablet Basic Information
  9.8.2 Eli Lilly and Company Orally Disintegrating Tablet Product Overview
  9.8.3 Eli Lilly and Company Orally Disintegrating Tablet Product Market Performance
  9.8.4 Eli Lilly and Company Business Overview
  9.8.5 Eli Lilly and Company Recent Developments
9.9 AstraZeneca
  9.9.1 AstraZeneca Orally Disintegrating Tablet Basic Information
  9.9.2 AstraZeneca Orally Disintegrating Tablet Product Overview
  9.9.3 AstraZeneca Orally Disintegrating Tablet Product Market Performance
  9.9.4 AstraZeneca Business Overview
  9.9.5 AstraZeneca Recent Developments
9.10 Bristol-Myers Squibb
  9.10.1 Bristol-Myers Squibb Orally Disintegrating Tablet Basic Information
  9.10.2 Bristol-Myers Squibb Orally Disintegrating Tablet Product Overview
  9.10.3 Bristol-Myers Squibb Orally Disintegrating Tablet Product Market Performance
  9.10.4 Bristol-Myers Squibb Business Overview
  9.10.5 Bristol-Myers Squibb Recent Developments
9.11 Conquer
  9.11.1 Conquer Orally Disintegrating Tablet Basic Information
  9.11.2 Conquer Orally Disintegrating Tablet Product Overview
  9.11.3 Conquer Orally Disintegrating Tablet Product Market Performance
  9.11.4 Conquer Business Overview
  9.11.5 Conquer Recent Developments

10 ORALLY DISINTEGRATING TABLET MARKET FORECAST BY REGION

10.1 Global Orally Disintegrating Tablet Market Size Forecast
10.2 Global Orally Disintegrating Tablet Market Forecast by Region
  10.2.1 North America Market Size Forecast by Country
  10.2.2 Europe Orally Disintegrating Tablet Market Size Forecast by Country
  10.2.3 Asia Pacific Orally Disintegrating Tablet Market Size Forecast by Region
  10.2.4 South America Orally Disintegrating Tablet Market Size Forecast by Country
  10.2.5 Middle East and Africa Forecasted Consumption of Orally Disintegrating Tablet by Country

11 FORECAST MARKET BY TYPE AND BY APPLICATION (2022-2028)

11.1 Global Orally Disintegrating Tablet Market Forecast by Type (2022-2028)
  11.1.1 Global Forecasted Sales of Orally Disintegrating Tablet by Type (2022-2028)
  11.1.2 Global Orally Disintegrating Tablet Market Size Forecast by Type (2022-2028)
  11.1.3 Global Forecasted Price of Orally Disintegrating Tablet by Type (2022-2028)
11.2 Global Orally Disintegrating Tablet Market Forecast by Application (2022-2028)
  11.2.1 Global Orally Disintegrating Tablet Sales (K Units) Forecast by Application
  11.2.2 Global Orally Disintegrating Tablet Market Size (M USD) Forecast by Application (2022-2028)

12 CONCLUSION AND KEY FINDINGSLIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Orally Disintegrating Tablet Market Size (M USD) Comparison by Region (M USD)
Table 5. Global Orally Disintegrating Tablet Sales (K Units) by Manufacturers (2017-2022)
Table 6. Global Orally Disintegrating Tablet Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Orally Disintegrating Tablet Revenue (M USD) by Manufacturers (2017-2022)
Table 8. Global Orally Disintegrating Tablet Revenue Share by Manufacturers (2017-2022)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Orally Disintegrating Tablet as of 2021)
Table 10. Global Market Orally Disintegrating Tablet Average Price (USD/Unit) of Key Manufacturers (2017-2022)
Table 11. Manufacturers Orally Disintegrating Tablet Sales Sites and Area Served
Table 12. Manufacturers Orally Disintegrating Tablet Product Type
Table 13. Global Orally Disintegrating Tablet Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Orally Disintegrating Tablet
Table 16. Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Orally Disintegrating Tablet Market Challenges
Table 22. Market Restraints
Table 23. Global Orally Disintegrating Tablet Sales by Type (K Units)
Table 24. Global Orally Disintegrating Tablet Market Size by Type (M USD)
Table 25. Global Orally Disintegrating Tablet Sales (K Units) by Type (2017-2022)
Table 26. Global Orally Disintegrating Tablet Sales Market Share by Type (2017-2022)
Table 27. Global Orally Disintegrating Tablet Market Size (M USD) by Type (2017-2022)
Table 28. Global Orally Disintegrating Tablet Market Size Share by Type (2017-2022)
Table 29. Global Orally Disintegrating Tablet Price (USD/Unit) by Type (2017-2022)
Table 30. Global Orally Disintegrating Tablet Sales (K Units) by Application
Table 31. Global Orally Disintegrating Tablet Market Size by Application
Table 32. Global Orally Disintegrating Tablet Sales by Application (2017-2022) & (K Units)
Table 33. Global Orally Disintegrating Tablet Sales Market Share by Application (2017-2022)
Table 34. Global Orally Disintegrating Tablet Sales by Application (2017-2022) & (M USD)
Table 35. Global Orally Disintegrating Tablet Market Share by Application (2017-2022)
Table 36. Global Orally Disintegrating Tablet Sales Growth Rate by Application (2017-2022)
Table 37. Global Orally Disintegrating Tablet Sales by Region (2017-2022) & (K Units)
Table 38. Global Orally Disintegrating Tablet Sales Market Share by Region (2017-2022)
Table 39. North America Orally Disintegrating Tablet Sales by Country (2017-2022) & (K Units)
Table 40. Europe Orally Disintegrating Tablet Sales by Country (2017-2022) & (K Units)
Table 41. Asia Pacific Orally Disintegrating Tablet Sales by Region (2017-2022) & (K Units)
Table 42. South America Orally Disintegrating Tablet Sales by Country (2017-2022) & (K Units)
Table 43. Middle East and Africa Orally Disintegrating Tablet Sales by Region (2017-2022) & (K Units)
Table 44. Teva Orally Disintegrating Tablet Basic Information
Table 45. Teva Orally Disintegrating Tablet Product Overview
Table 46. Teva Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 47. Teva Business Overview
Table 48. Teva Orally Disintegrating Tablet SWOT Analysis
Table 49. Teva Recent Developments
Table 50. Merck Orally Disintegrating Tablet Basic Information
Table 51. Merck Orally Disintegrating Tablet Product Overview
Table 52. Merck Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 53. Merck Business Overview
Table 54. Merck Orally Disintegrating Tablet SWOT Analysis
Table 55. Merck Recent Developments
Table 56. Mylan Orally Disintegrating Tablet Basic Information
Table 57. Mylan Orally Disintegrating Tablet Product Overview
Table 58. Mylan Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 59. Mylan Business Overview
Table 60. Mylan Orally Disintegrating Tablet SWOT Analysis
Table 61. Mylan Recent Developments
Table 62. Pfizer Orally Disintegrating Tablet Basic Information
Table 63. Pfizer Orally Disintegrating Tablet Product Overview
Table 64. Pfizer Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 65. Pfizer Business Overview
Table 66. Pfizer Orally Disintegrating Tablet SWOT Analysis
Table 67. Pfizer Recent Developments
Table 68. Johnson and Johnson Orally Disintegrating Tablet Basic Information
Table 69. Johnson and Johnson Orally Disintegrating Tablet Product Overview
Table 70. Johnson and Johnson Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 71. Johnson and Johnson Business Overview
Table 72. Johnson and Johnson Orally Disintegrating Tablet SWOT Analysis
Table 73. Johnson and Johnson Recent Developments
Table 74. GSK Orally Disintegrating Tablet Basic Information
Table 75. GSK Orally Disintegrating Tablet Product Overview
Table 76. GSK Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 77. GSK Business Overview
Table 78. GSK Recent Developments
Table 79. Otsuka Orally Disintegrating Tablet Basic Information
Table 80. Otsuka Orally Disintegrating Tablet Product Overview
Table 81. Otsuka Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 82. Otsuka Business Overview
Table 83. Otsuka Recent Developments
Table 84. Eli Lilly and Company Orally Disintegrating Tablet Basic Information
Table 85. Eli Lilly and Company Orally Disintegrating Tablet Product Overview
Table 86. Eli Lilly and Company Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 87. Eli Lilly and Company Business Overview
Table 88. Eli Lilly and Company Recent Developments
Table 89. AstraZeneca Orally Disintegrating Tablet Basic Information
Table 90. AstraZeneca Orally Disintegrating Tablet Product Overview
Table 91. AstraZeneca Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Recent Developments
Table 94. Bristol-Myers Squibb Orally Disintegrating Tablet Basic Information
Table 95. Bristol-Myers Squibb Orally Disintegrating Tablet Product Overview
Table 96. Bristol-Myers Squibb Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 97. Bristol-Myers Squibb Business Overview
Table 98. Bristol-Myers Squibb Recent Developments
Table 99. Conquer Orally Disintegrating Tablet Basic Information
Table 100. Conquer Orally Disintegrating Tablet Product Overview
Table 101. Conquer Orally Disintegrating Tablet Sales (K Units), Market Size (M USD), Price (USD/Unit) and Gross Margin (2017-2022)
Table 102. Conquer Business Overview
Table 103. Conquer Recent Developments
Table 104. Global Orally Disintegrating Tablet Sales Forecast by Region (K Units)
Table 105. Global Orally Disintegrating Tablet Market Size Forecast by Region (M USD)
Table 106. North America Orally Disintegrating Tablet Sales Forecast by Country (2022-2028) & (K Units)
Table 107. North America Orally Disintegrating Tablet Market Size Forecast by Country (2022-2028) & (M USD)
Table 108. Europe Orally Disintegrating Tablet Sales Forecast by Country (2022-2028) & (K Units)
Table 109. Europe Orally Disintegrating Tablet Market Size Forecast by Country (2022-2028) & (M USD)
Table 110. Asia Pacific Orally Disintegrating Tablet Sales Forecast by Region (2022-2028) & (K Units)
Table 111. Asia Pacific Orally Disintegrating Tablet Market Size Forecast by Region (2022-2028) & (M USD)
Table 112. South America Orally Disintegrating Tablet Sales Forecast by Country (2022-2028) & (K Units)
Table 113. South America Orally Disintegrating Tablet Market Size Forecast by Country (2022-2028) & (M USD)
Table 114. Middle East and Africa Orally Disintegrating Tablet Consumption Forecast by Country (2022-2028) & (Units)
Table 115. Middle East and Africa Orally Disintegrating Tablet Market Size Forecast by Country (2022-2028) & (M USD)
Table 116. Global Orally Disintegrating Tablet Sales Forecast by Type (2022-2028) & (K Units)
Table 117. Global Orally Disintegrating Tablet Market Size Forecast by Type (2022-2028) & (M USD)
Table 118. Global Orally Disintegrating Tablet Price Forecast by Type (2022-2028) & (USD/Unit)
Table 119. Global Orally Disintegrating Tablet Sales (K Units) Forecast by Application (2022-2028)
Table 120. Global Orally Disintegrating Tablet Market Size Forecast by Application (2022-2028) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Orally Disintegrating Tablet
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Orally Disintegrating Tablet Market Size (M USD), 2017-2028
Figure 5. Global Orally Disintegrating Tablet Market Size (M USD) (2017-2028)
Figure 6. Global Orally Disintegrating Tablet Sales (K Units) & (2017-2028)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Orally Disintegrating Tablet Market Size (M USD) by Country (M USD)
Figure 11. Orally Disintegrating Tablet Sales Share by Manufacturers in 2020
Figure 12. Global Orally Disintegrating Tablet Revenue Share by Manufacturers in 2020
Figure 13. Orally Disintegrating Tablet Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 14. Global Market Orally Disintegrating Tablet Average Price (USD/Unit) of Key Manufacturers in 2020
Figure 15. The Global 5 and 10 Largest Players: Market Share by Orally Disintegrating Tablet Revenue in 2021
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Orally Disintegrating Tablet Market Share by Type
Figure 18. Sales Market Share of Orally Disintegrating Tablet by Type (2017-2022)
Figure 19. Sales Market Share of Orally Disintegrating Tablet by Type in 2021
Figure 20. Market Size Share of Orally Disintegrating Tablet by Type (2017-2022)
Figure 21. Market Size Market Share of Orally Disintegrating Tablet by Type in 2020
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Orally Disintegrating Tablet Market Share by Application
Figure 24. Global Orally Disintegrating Tablet Sales Market Share by Application (2017-2022)
Figure 25. Global Orally Disintegrating Tablet Sales Market Share by Application in 2021
Figure 26. Global Orally Disintegrating Tablet Market Share by Application (2017-2022)
Figure 27. Global Orally Disintegrating Tablet Market Share by Application in 2020
Figure 28. Global Orally Disintegrating Tablet Sales Growth Rate by Application (2017-2022)
Figure 29. Global Orally Disintegrating Tablet Sales Market Share by Region (2017-2022)
Figure 30. North America Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 31. North America Orally Disintegrating Tablet Sales Market Share by Country in 2020
Figure 32. U.S. Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 33. Canada Orally Disintegrating Tablet Sales (K Units) and Growth Rate (2017-2022)
Figure 34. Mexico Orally Disintegrating Tablet Sales (Units) and Growth Rate (2017-2022)
Figure 35. Europe Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 36. Europe Orally Disintegrating Tablet Sales Market Share by Country in 2020
Figure 37. Germany Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 38. France Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 39. U.K. Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 40. Italy Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 41. Russia Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 42. Asia Pacific Orally Disintegrating Tablet Sales and Growth Rate (K Units)
Figure 43. Asia Pacific Orally Disintegrating Tablet Sales Market Share by Region in 2020
Figure 44. China Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 45. Japan Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 46. South Korea Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 47. India Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 48. Southeast Asia Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 49. South America Orally Disintegrating Tablet Sales and Growth Rate (K Units)
Figure 50. South America Orally Disintegrating Tablet Sales Market Share by Country in 2020
Figure 51. Brazil Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 52. Argentina Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 53. Columbia Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 54. Middle East and Africa Orally Disintegrating Tablet Sales and Growth Rate (K Units)
Figure 55. Middle East and Africa Orally Disintegrating Tablet Sales Market Share by Region in 2020
Figure 56. Saudi Arabia Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 57. UAE Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 58. Egypt Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 59. Nigeria Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 60. South Africa Orally Disintegrating Tablet Sales and Growth Rate (2017-2022) & (K Units)
Figure 61. Global Orally Disintegrating Tablet Sales Forecast by Volume (2017-2028) & (K Units)
Figure 62. Global Orally Disintegrating Tablet Market Size Forecast by Value (2017-2028) & (M USD)
Figure 63. Global Orally Disintegrating Tablet Sales Market Share Forecast by Type (2022-2028)
Figure 64. Global Orally Disintegrating Tablet Market Share Forecast by Type (2022-2028)
Figure 65. Global Orally Disintegrating Tablet Sales Forecast by Application (2022-2028)
Figure 66. Global Orally Disintegrating Tablet Market Share Forecast by Application (2022-2028)